Dova Pharmaceuticals' IPO

Dova Pharmaceuticals raised a round of funding on June 29, 2017. Investors include Public.

Dova Pharmaceuticals (NASDAQ: DOVA) is focused on acquiring, developing, and commercializing drug candidates for diseases that are treated by specialist physicians, with an initial focus on addressing…

Articles about Dova Pharmaceuticals' IPO: